(−)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase
- 1 January 1996
- book chapter
- Published by Springer Nature
- Vol. 48, 45-59
- https://doi.org/10.1007/978-3-7091-7494-4_5
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- The effects of administration of monoamine oxidase‐B inhibitors on rat striatal neurone responses to dopamineBritish Journal of Pharmacology, 1994
- Ca2+-dependent permeabilization of the inner mitochondrial membrane by 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS)Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1994
- Influence of treatment with l-deprenyl on the structure of the cerebellar cortex of aged ratsMechanisms of Ageing and Development, 1994
- The concept of astrocyte-kinetic drug in the treatment of neurodegenerative diseases: Evidence for l-deprenyl-induced activation of reactive astrocytesNeurochemistry International, 1994
- Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult ratsJournal of Neuroscience, 1994
- Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibitionJournal of Neuroscience, 1993
- L-Deprenyl increases GFAP immunoreactivity selectively in activated astrocytes in rat brainNeuroReport, 1993
- Intranigral Iron Injection Induces Behavioral and Biochemical “Parkinsonism” in RatsJournal of Neurochemistry, 1991
- cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties.Proceedings of the National Academy of Sciences, 1988
- IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASEThe Lancet, 1977